1100 Van Ness Avenue - UCSF Immunogenetics and Transplantation Lab (ITL)
Summary
SCH Number
2020080426
Public Agency
University of California, San Francisco
Document Title
1100 Van Ness Avenue - UCSF Immunogenetics and Transplantation Lab (ITL)
Document Type
NOE - Notice of Exemption
Received
Posted
8/25/2020
Present Land Use
Medical Office Space
Document Description
The proposed action is the lease of about 14,000 square feet of existing space at 1100 Van Ness Avenue for UCSF’s Immunogenetics and Transplantation Laboratory (ITL). The existing building at 1100 Van Ness is a medical office building newly constructed as part of the Sutter Health California Pacific Medical Center Van Ness campus. Tenant improvements are proposed, consisting of the build-out of the space to include offices, lab and support space.
Contact Information
Name
Diane Wong
Agency Name
University of California, San Francisco (UCSF)
Contact Types
Lead/Public Agency
Phone
Email
Name
Agency Name
University of California, San Francisco
Contact Types
Project Applicant
Location
Counties
San Francisco
Regions
Citywide
Cross Streets
1100 Van Ness Avenue at Geary Boulevard
Notice of Exemption
Exempt Status
Categorical Exemption
Type, Section or Code
15301
Reasons for Exemption
CEQA Guidelines Sections 15301, Class 1 Existing Facilities, exempts from CEQA review projects that involve minor alterations to existing structures involving negligible or no expansion of use. The proposed action is exempt from environmental review under CEQA Guidelines Section 15301 Existing Facilities because the site is an existing building within a dense urban area, the space was developed for clinical use, and only minor physical alterations are proposed by UCSF. No significant impacts would result from the proposed lease. In addition, none of the CEQA Guidelines Section 15300.2 exceptions to the use of the categorical exemption applies to the proposed project.
Attachments
Notice of Exemption
Disclaimer: The Governor’s Office of Planning and Research (OPR) accepts no responsibility for the content or accessibility of these documents. To obtain an attachment in a different format, please contact the lead agency at the contact information listed above. For more information, please visit OPR’s Accessibility Site.